174 related articles for article (PubMed ID: 30990090)
1. The clinical features and reproductive prognosis of ovarian neoplasms with hyperandrogenemia: a retrospective analysis of 33 cases.
Shu S; Deng S; Tian JQ; Chen R; Sun JA; Yu Q; Zhu Liu F; Huang LR; Pan YL; Yang XJ; Fan BQ; Liu YH
Gynecol Endocrinol; 2019 Sep; 35(9):825-828. PubMed ID: 30990090
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
Perez Lana M; Demayo S; Monastero A; Nolting M
Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
[TBL] [Abstract][Full Text] [Related]
3. Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia.
Mudraje S; Shetty S; Guruvare S; Kudva R
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36007974
[TBL] [Abstract][Full Text] [Related]
4. Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman.
Szeliga A; Zysnarska A; Podfigurna A; Maciejewska-Jeske M; Moszyński R; Sajdak S; Jasiński P; Frankowski A; Genazzani AR; Męczekalski B
Gynecol Endocrinol; 2020 Apr; 36(4):303-307. PubMed ID: 31718336
[TBL] [Abstract][Full Text] [Related]
5. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
6. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
Rojewska P; Meczekalski B; Bala G; Luisi S; Podfigurna A
Gynecol Endocrinol; 2022 Jul; 38(7):537-542. PubMed ID: 35647677
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian tumors with endocrine function].
Guo LN; Liu TH; Sun AJ; Zhou Q
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian gonadal tumors in materials of the clinic of gynecological endocrinology of the Medical Academy in Poznań (1970-1998)].
Warenik-Szymankiewicz A; Słopień R; Kedzia H; Grotowski W
Ginekol Pol; 1999 May; 70(5):242-5. PubMed ID: 10462956
[TBL] [Abstract][Full Text] [Related]
9. A poorly differentiated Sertoli-Leydig cell tumour associated with an ovarian sex cord tumour with annular tubules in a woman with Peutz-Jeghers syndrome.
Hales SA; Cree IA; Pinion S
Histopathology; 1994 Oct; 25(4):391-3. PubMed ID: 7835846
[No Abstract] [Full Text] [Related]
10. Sertoli-Leydig cell tumour in a 13-year-old girl.
Böttcher B; Hinney B; Keyser J; Kühnle I; Schweyer S; Emons G
Gynecol Endocrinol; 2011 Feb; 27(2):107-9. PubMed ID: 20586549
[TBL] [Abstract][Full Text] [Related]
11. Androblastoma of the ovary: clinical, diagnostic and histopathologic features.
Fleckenstein G; Sattler B; Hinney B; Wuttke W; Osmers R; Emons G
Onkologie; 2001 Jun; 24(3):286-91. PubMed ID: 11455224
[TBL] [Abstract][Full Text] [Related]
12. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
Dunne C; Havelock JC
J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
[TBL] [Abstract][Full Text] [Related]
13. Expression of Key Androgen-Activating Enzymes in Ovarian Steroid Cell Tumor, Not Otherwise Specified.
Valenzuela Scheker E; Kathuria A; Esnakula A; Sasano H; Yamazaki Y; Tevosian S; Auchus RJ; Ghayee HK; Dhir G
J Investig Med High Impact Case Rep; 2020; 8():2324709620933416. PubMed ID: 32590918
[TBL] [Abstract][Full Text] [Related]
14. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
15. Sertoli Leydig Cell Tumour Initially Misdiagnosed as Polycystic Ovarian Syndrome and Congenital Adrenal Hyperplasia: A Case Report.
Paudyal P; Gurung G; Baral J; Kharel N
JNMA J Nepal Med Assoc; 2020 Nov; 58(231):923-926. PubMed ID: 34506429
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenism produced by ovarian tumors in women at different life stages.
Fux-Otta C; Szafryk de Mereshian P; López de Corominas M; Fuster M; López CR
Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(2):122-6. PubMed ID: 25365199
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
[TBL] [Abstract][Full Text] [Related]
19. Giant mixed Sertoli-Leydig-Granulosa sex cord tumor of the testis; clinical, histopathological, and radiological features: a case report.
Tahaineh S; Mughli RA; Fallatah M
Pan Afr Med J; 2017; 27():51. PubMed ID: 28819473
[TBL] [Abstract][Full Text] [Related]
20. Case report: an identical twin with Sertoli-Leydig cell tumor.
Cho K; Havelock JC; Gilks B; Dunne C
Gynecol Endocrinol; 2018 Jul; 34(7):563-566. PubMed ID: 29366348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]